Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-15 · accession 0001104659-24-090984 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-19 | 2024-08-15+ | INSP | Ban Randy | Chief Commercial Off | M - OptEx | $42.15 | +21.0K | 19.2K | New | +$885.1K |
| DM | 2024-08-19 | 2024-08-15+ | INSP | Ban Randy | Chief Commercial Off | S - Sale+OE | $192.05 | -21.0K | 3,056 | -87% | -$4.03M |
| DM | 2024-08-19 | 2024-08-15+ | INSP | Ban Randy | Chief Commercial Off | M - OptEx | $0.00 | -21.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-16 | M | A | 4,861 | $42.15 | 7,917 | D | — | — | |
| 2 | Common | Common Stock | 2024-08-16 | S | D | 900 | $187.10 | 7,017 | D | — | — | (F8) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $186.90 to $187.71. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2024-08-16 | S | D | 3,066 | $188.66 | 3,951 | D | — | — | (F9) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.255 to $189.24. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote . |
| 4 | Common | Common Stock | 2024-08-16 | S | D | 895 | $189.64 | 3,056 | D | — | — | (F10) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $189.26 to $189.855. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2024-08-15 | M | A | 16,139 | $42.15 | 19,195 | D | — | — | (F1) Includes 27 shares acquired under the Issuer's 2018 Employee Stock Purchase Plan since the Reporting Person's Form 4 dated February 27, 2024. |
| 6 | Common | Common Stock | 2024-08-15 | S | D | 776 | $189.06 | 18,419 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $188.995 to $189.285. The Reporting Person undertakes to provide Inspire Medical Systems, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 7 | Common | Common Stock | 2024-08-15 | S | D | 1,659 | $190.20 | 16,760 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $190.08 to $190.845. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 8 | Common | Common Stock | 2024-08-15 | S | D | 2,072 | $191.92 | 14,688 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $191.225 to $192.18. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 9 | Common | Common Stock | 2024-08-15 | S | D | 1,150 | $192.60 | 13,538 | D | — | — | (F5) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.26 to $193.22. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 10 | Common | Common Stock | 2024-08-15 | S | D | 8,132 | $193.92 | 5,406 | D | — | — | (F6) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $193.4 to $194.32. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 11 | Common | Common Stock | 2024-08-15 | S | D | 2,350 | $194.91 | 3,056 | D | — | — | (F7) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.81 to $195.15. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 12 | Derivative | Stock Option (Right to Buy) | 2024-08-15 | M | D | 16,139 | $0.00 | 4,861 | D | $42.15 · — to 2028-12-18 | 16,139 Common Stock | (F11) The option is fully vested and exercisable. |
| 13 | Derivative | Stock Option (Right to Buy) | 2024-08-16 | M | D | 4,861 | $0.00 | 0 | D | $42.15 · — to 2028-12-18 | 4,861 Common Stock | (F11) The option is fully vested and exercisable. |